精准医疗软体市场规模、份额及成长分析（按交付类型、应用、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，精准医疗软体市场规模将达到 16.2 亿美元，到 2025 年将达到 18 亿美元，到 2033 年将达到 42.8 亿美元，在预测期（2026-2033 年）内，复合年增长率将达到 11.4%。

精准医疗软体市场正经历强劲成长，这主要得益于技术进步和对个人化医疗解决方案日益增长的需求。该软体使医疗服务提供者能够有效地收集、分析和利用大量的患者数据，从而製定个人化的治疗方案，充分考虑个体的遗传、环境和生活方式等因素。关键成长要素包括慢性病发病率的上升、基因组学和蛋白​​质组学的进步、电子健康记录（EHR）的日益普及以及政府的积极支持。此外，将人工智慧（AI）和机器学习演算法整合到精准医疗软体中，预计将进一步加速市场发展，为不断变化的医疗环境中的创新创造机会，并有助于改善患者的治疗效果。

精准医疗软体市场驱动因素

推动精准医疗软体市场成长的关键因素之一是人们对个人化医疗解决方案日益增长的需求。精准医疗专注于根据个体独特的基因组成、生活方式选择和环境影响，提供客製化的治疗和介入措施。先进的基因测序技术与巨量资料分析能力的结合，正在促进精准医疗融入日常临床实务。精准医疗软体使医疗服务提供者能够处理大量的患者数据，包括基因图谱、病历和即时监测数据，从而做出更个人化和明智的治疗决策。患者和医疗专业人员对精准医疗益处的认识不断提高，进一步推动了对辅助软体解决方案的需求。

精准医疗软体市场面临的限制因素

精准医疗软体市场面临的主要挑战之一是其复杂且高成本的实施和整合过程。满足精准医疗的需求需要全面的软体解决方案来收集、储存和分析大量的基因组和临床数据。然而，医疗机构常常受到互通性挑战、资料隐私问题以及医务人员需要接受大量培训等问题的阻碍。资金挑战也是一大障碍。实施、维护和升级这些复杂软体系统的成本可能非常高昂，尤其对于小规模的医疗机构和资源匮乏的地区而言，这可能会阻碍它们采用这些创新技术。

精准医疗软体市场趋势

精准医疗软体市场目前正受到多项变革性趋势的影响，这些趋势正在强化其结构。其中显着的趋势包括人工智慧 (AI) 和机器学习 (ML) 技术的日益普及，这些技术能够提高诊断准确性，并根据患者的个别特征量身定制治疗方案。此外，向云端解决方案的转型势头强劲，有助于在安全的环境中高效储存、分析和共享海量的基因组和临床数据共用。同时，互通性和数据标准化也日益受到重视，这有助于整合不同的医疗保健系统，并加强医疗专业人员之间的协作。这些趋势正在汇聚，推动精准医疗软体功能的持续发展，最终目标是改善患者照护和健康结果。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析及其影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 监管环境
• 专利分析
• 案例研究

全球精准医疗软体市场规模（依交付方式及复合年增长率划分）（2026-2033 年）

• 网路和云端
• 本地部署

全球精准医疗软体市场规模（依应用领域及复合年增长率划分）（2026-2033 年）

• 肿瘤学
• 药物基因组学
• 罕见疾病

全球精准医疗软体市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医疗保健提供者
• 研究中心和学术机构
• 製药和生物技术公司

全球精准医疗软体市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• IBM Watson Health
• Oracle Corporation
• SAP SE
• SAS Institute Inc.
• Microsoft Corporation
• Flatiron Health, Inc.
• Syapse, Inc.
• Fabric Genomics, Inc.
• N-of-One, Inc.
• Gene42, Inc.
• PierianDx
• LifeOmic
• Tempus Labs, Inc.
• 2bPrecise LLC
• Human Longevity, Inc.
• GNS Healthcare
• Seven Bridges Genomics
• WuXi NextCODE
• Foundation Medicine, Inc.
• Strand Life Sciences

结论与建议

Precision Medicine Software Market size was valued at USD 1.62 Billion in 2024 and is poised to grow from USD 1.8 Billion in 2025 to USD 4.28 Billion by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).

The precision medicine software market is witnessing robust growth, fueled by technological advancements and a rising demand for personalized healthcare solutions. This software empowers healthcare providers to efficiently gather, analyze, and apply extensive patient data, allowing for customized treatment plans that consider individual genetic, environmental, and lifestyle variables. Critical growth drivers include the increasing prevalence of chronic diseases, progress in genomics and proteomics, a surge in electronic health record adoption, and favorable government support. Additionally, the incorporation of artificial intelligence and machine learning algorithms into precision medicine software is poised to enhance market momentum, creating further opportunities for innovation and improved patient outcomes in the evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Precision Medicine Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Precision Medicine Software Market Segments Analysis

Global Precision Medicine Software Market is segmented by delivery mode, application, end user and region. Based on delivery mode, the market is segmented into web & cloud-based and on-premises. Based on application, the market is segmented into oncology, pharmacogenomics and rare diseases. Based on end user, the market is segmented into healthcare providers, research centers and academic institutes and pharmaceutical and biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Precision Medicine Software Market

A significant factor propelling the growth of the precision medicine software market is the rising demand for personalized healthcare solutions. Precision medicine focuses on delivering tailored treatments and interventions based on an individual's unique genetic composition, lifestyle choices, and environmental influences. The emergence of sophisticated genomic sequencing technologies, coupled with the capabilities of big data analytics, has enhanced the integration of precision medicine into everyday clinical practice. Precision medicine software empowers healthcare providers to process extensive patient data, including genetic profiles, medical histories, and real-time monitoring, enabling them to make more customized and informed treatment decisions. Increased awareness among patients and healthcare professionals about the advantages of precision medicine further fuels the demand for supportive software solutions.

Restraints in the Precision Medicine Software Market

One significant challenge facing the precision medicine software market is the intricate and costly nature of its implementation and integration processes. The demands of precision medicine require comprehensive software solutions for collecting, storing, and analyzing extensive genomic and clinical data. However, healthcare organizations often encounter difficulties due to interoperability challenges, data privacy issues, and the necessity for thorough training of healthcare staff. The financial aspect also poses a barrier, as the expenses related to acquiring, maintaining, and upgrading these sophisticated software systems can be prohibitively high, particularly for smaller healthcare facilities and regions with limited resources, thereby hindering their ability to adopt such innovative technologies.

Market Trends of the Precision Medicine Software Market

The precision medicine software market is currently influenced by several transformative trends that are enhancing its landscape. A notable trend is the rising incorporation of artificial intelligence (AI) and machine learning (ML) technologies, which boost diagnostic accuracy and enable the customization of treatment strategies based on individual patient profiles. Additionally, the shift towards cloud-based solutions is gaining momentum, facilitating efficient storage, analysis, and sharing of extensive genomic and clinical datasets in a secure environment. There is also an increasing emphasis on interoperability and data standardization, which enhances the integration of diverse healthcare systems and fosters collaboration among medical professionals. These trends are collectively propelling the evolving capabilities of precision medicine software, ultimately aiming to improve patient care and health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Precision Medicine Software Market Size by Delivery Mode & CAGR (2026-2033)

• Market Overview
• Web & Cloud-Based
• On-Premises

Global Precision Medicine Software Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Pharmacogenomics
• Rare Diseases

Global Precision Medicine Software Market Size by End User & CAGR (2026-2033)

• Market Overview
• Healthcare Providers
• Research Centers and Academic Institutes
• Pharmaceutical and Biotechnology Companies

Global Precision Medicine Software Market Size & CAGR (2026-2033)

• North America (Delivery Mode, Application, End User)
  • US
  • Canada
• Europe (Delivery Mode, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Delivery Mode, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Delivery Mode, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Delivery Mode, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAP SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS Institute Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syapse, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fabric Genomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• N-of-One, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gene42, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PierianDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeOmic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus Labs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 2bPrecise LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Longevity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GNS Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seven Bridges Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi NextCODE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foundation Medicine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strand Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation